Umecrine Cognition AB
556698-3655ActiveDeveloping novel drugs for neurological disorders caused by neuroinflammation.
Biotechnology Companyumecrinecognition.com
Oversigt
- 1–4
- Medarbejdere
- ≤1t SEK
- Omsætning
- 2006
- Grundlagt
Nøglebeslutningstagere
Viktor Drvota
CEO
@umecrine.se+46852XXXXXX
Magnus Doverskog
Chief Executive Officer
@umecrine.se
Pernilla Sandwall
COO (Chief Operating Officer)
@umecrine.se
Thomas P. Blackburn
Non-executive Director
+6 flere kontakter i Funnelfeedr
Beskrivelse
Umecrine Cognition AB is a biotechnology company focused on developing novel treatments for neurological disorders in the brain. Their primary scientific focus is on GABAA receptor modulating steroid antagonists. They aim to treat cognitive disorders caused by neuroinflammation resulting from a wide...